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appeal. Here, the stage 2 LOD score has no real meaning
but just serves to act as a benchmark that must be at-
tained. Values of 3.0, 3.3, and 3.6 are used, but no
justification is given for choosing them; nor could there
be one. It would be perfectly reasonable to find the
power of a procedure to attain a certain LOD score or
to attain a statistic having a certain P value (type I–error
probability). What makes no sense is to aim to attain a
certain LOD score in the second stage but then to achieve
a specified type I–error probability overall by manipu-
lating the threshold applicable for the first stage. The
more natural approach, which I am sure would yield
completely different results with regard to power and
efficiency, would be to fix the threshold for the first stage
(probably at .5–1.0) and, in the second stage, to aim
either for some predetermined LOD score or for a LOD
producing a certain overall P value.
The effects of Holmans and Craddock’s approach are
clear to see. The stage 1 criterion has to be made high
enough so that only a small number of unlinked regions
will achieve it and hence go on to produce false-positive
results in stage 2. The more subjects and markers that
are typed in the first stage, the more likely it is that high
LOD scores will be thrown up by chance, and hence the
higher the stage 1 criterion must be set. The higher this
criterion is, the harder it may be for a truly linked locus
to achieve it, and so such loci may be more frequently
discarded. Thus, doing more genotyping in the first stage
generally leads to a reduction in power, despite involving
an increase in the total amount of genotyping required.
The first scenario that Holmans and Craddock present
illustrates this clearly. A wide, 20-cM grid is used for
stage 1, narrowing to 10 cM in stage 2, and the LOD
score to be taken to indicate linkage, after stage 2, is
chosen to be 3. When only 100 of the 200 sib pairs are
typed, the threshold to move from stage 1 to stage 2 is
set to a modest and sensible .89, and the overall power
is .62. However, when all 200 pairs are typed, the stage
1 threshold has to be raised to 2.14, so many true link-
ages are missed, and the power falls to .57. Using 100
pairs together with their parents needs a threshold of
1.57 and yields a power of .52. Finally, initially using
all 200 pairs and their parents apparently demands a
stage 1 threshold of 3.1 and has a power of only .54.
This would mean that, if one got a LOD of 3.05 with
the initial 20-cM grid scan, one would not follow up
this finding, even though it would count as a positive
result if it were to be found in stage 2.
Given that genotyping is becoming ever cheaper and
easier, given that linkage can easily be missed in sib-pair
samples, and given that performing a genome scan but
missing a disease locus is highly undesirable, my own
personal view is that the initial scan should probably be
fairly thorough, using all available subjects and a rela-
tively narrow marker grid.
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Reply to Curtis
To the Editor:
Curtis (1998 [in this issue]) has raised some criticisms
regarding our paper on efficient strategies for genome
screening for linkage (Holmans and Craddock 1997).
We reply to them as follows:
Curtis has said that our decision to fix the stage 2
criterion “lacks any intrinsic appeal” and “makes no
sense.” However, we would like to point out that judge-
ments regarding the significance of a linkage study are
generally based on the final LOD score obtained. There-
fore, to facilitate comparison between the various strat-
egies, it is desirable that a given stage 2 LOD score
should correspond to the same significance level in all
the strategies, as far as possible. This can most easily be
done by fixing the stage 2 criterion and varying the stage
1 criterion, to obtain the desired type I error probability.
In practice, one would not regard such criteria as bench-
marks of “significant” versus “nonsignificant” link-
age—their purpose is to ensure a fair comparison of the
power of the various strategies and as a guide to which
LOD scores correspond at P value of X.05.
We chose 3.6 as one of our criteria since this was
recommended by Lander and Kruglyak (1995) as cor-
responding to a genomewide P value of .05 and is in
widespread use. The criterion of 3.0 was chosen as the
traditional criterion for significant linkage. The criterion
3.3 was adopted when it became clear that 3.6 was too
stringent for the strategies to give a P value of .05. It is
clear from our results that higher criteria would make
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Table 1
Performance of Two-Stage Strategies
Grid and
Stage 1 Sample a
Stage 2 LOD
Criterion b Power c
No. (SD) of
Genotypings
20 cM/10 cM:
100 Pairs 2.96 .622 47,359 (400)
200 Pairs 3.15 .709 78,166 (333)
100 Pairs
 parents 3.10 .665 78,493 (350)
200 Pairs
 parents 3.15 .722 140,134 (265)
20 cM/5 cM:
100 Pairs 3.10 .652 59,180 (705)
200 Pairs 3.25 .782 90,829 (619)
100 Pairs
 parents 3.19 .717 91,209 (654)
200 Pairs
 parents 3.41 .778 154,671 (562)
10 cM/5 cM:
100 Pairs 3.19 .733 94,174 (627)
200 Pairs 3.41 .783 156,274 (527)
100 Pairs
 parents 3.19 .785 155,800 (564)
200 Pairs
 parents 3.41 .786 278,908 (423)
a Grid-tightening strategies are denoted as the intermarker interval
in stage 1 (to the left of the slash) followed by that in stage 2 (to the
right of the slash). The stage 1 LOD-score criterion is .9; .l  2S
b Fixed to make genomewide type I error probability ∼.05.
c SD X.01.
it impossible for a type I error P value of .05 to be
obtained, whereas lower criteria would reduce efficiency
by requiring an excessively high stage 1 criterion.
As noted by Curtis, it is also possible to fix the stage
1 criterion and to vary the stage 2 criterion, although
we do not see why this approach should be regarded as
“more natural.”. What is more important, we disagree
with Curtis’s comment (made without any justification)
that such an approach “would yield completely different
results”, provided that the stage 2 criteria were chosen
to produce the same overall P value. Our reasoning is
as follows: Strategies using narrow grids in stage 1 will
produce more false-positive results to be followed up in
stage 2, because of the greater number of loci being
tested. Therefore, a higher stage 2 criterion will be nec-
essary, thereby reducing power. In addition, the degree
of dependence between the stage 1 test and the stage 2
test is increased for strategies in which a large proportion
of the total sample is typed in stage 1, because of the
similarity in the data analyzed in the two stages. This
means that loci giving false-positive results in stage 1
are more likely also to give high LOD scores in stage 2.
Again, a higher stage 2 criterion will be needed. It is
therefore quite possible that strategies involving a large
amount of genotyping in stage 1 may not increase power,
as we found in our simulations.
Following Curtis’s suggestion, we investigated the
power of the various strategies when, as suggested, the
stage 1 criterion was fixed and the stage 2 criterion was
varied to give a type I error P value of .05. A stage 1
criterion of .9 was used—this is similar to the stage 1
criteria of the best-performing tests in our original paper
and also is within the range suggested by Curtis. The
results are displayed in table 1. Fixing the stage 1 cri-
terion certainly improves the performance of the strat-
egies in which the whole sample (200 pairs  parents)
is typed in stage 1, compared with the results displayed
in our original paper. However, it can still be seen that
typing the whole sample in stage 1 gives, at best, a min-
imal power increase over that of strategies in which only
the affected pairs are typed, while requiring considerably
more genotyping. Use of a tight (10-cM) grid in stage 1
gives no more power than the use of a wide (20-cM)
grid, and it requires a large increase in genotyping. The
main conclusions of our original paper—that is, that
both sample-splitting and grid-tightening increase effi-
ciency and that a relatively wide initial grid is preferable
to a narrow one—therefore stand.
Of course, if the stage 2 criterion is “predetermined,”
as suggested by Curtis, then strategies involving large
amounts of genotyping in stage 1 will give the highest
“power”—that is, the highest number of LOD scores
exceeding the criterion. However, this would be mean-
ingless, since such strategies would also have the highest
number of false positives.
By means of the reasoning mentioned above, the ex-
planation for the seemingly counterintuitive results
noted by Curtis becomes apparent. Strategies in which
a large number of loci are typed in stage 1 require a
higher stage 1 test criterion, to restrict the number of
false positives being tested in stage 2 to the correct level.
Similarly, strategies using a high proportion of the sam-
ple in stage 1 require an increased stage 1 test criterion,
to offset the increased dependence of the stage 1 and
stage 2 tests. We can therefore see that strategies that
utilize a “more thorough search in the first stage” require
a higher stage 1 criterion, for a given type I error prob-
ability. This is why the power of such strategies may be
reduced, despite the increase in the amount of genotyp-
ing, as Curtis himself notes. The numerical example that
Curtis gives illustrates the point perfectly.
As Curtis notes, in the extreme case, in which the
entire sample is genotyped in stage 1, the required stage
1 criterion may actually exceed the stage 2 criterion.
However, we are not recommending such strategies; we
are merely quoting the stage 1 criteria that make these
strategies as efficient as possible, given the stage 2 cri-
terion. These strategies perform very poorly, requiring a
large amount of genotyping and giving only low power.
In fact, the implausibly high stage 1 criteria should act
as a warning not to use these strategies—in the Discus-
sion section of our original paper (Holmans and Crad-
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dock 1997), we note that the best-performing strategies
have stage 1 criteria of ∼1.
It is true that we have not considered multipoint anal-
ysis, and this would be an interesting area for further
work. Given that our conclusions hold up under two-
locus analysis (Holmans and Craddock 1997), we would
be hopeful that they would also be true under multilocus
analysis.
In conclusion, although there is certainly scope for
further work—particularly that involving multilocus
analysis—we disagree strongly with Curtis’s statements
that our work is “fundamentally flawed” and that our
results “do not provide useful information.” The results
presented here show that the alternative approach ad-
vocated by Curtis would result in conclusions similar to
ours, despite his assertions to the contrary.
PETER HOLMANS AND NICK CRADDOCK∗
Division of Psychological Medicine
University of Wales College of Medicine
Heath Park
Cardiff
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